Abstract
The purpose of this study was to evaluate the potential therapeutic effect of cholecystokinin octapeptide (CCK-8) on collagen-induced arthritis (CIA), an accepted murine experimental disease model with diverse histopathological features similar to human rheumatoid arthritis (RA). CIA was induced in DBA/1J mice by immunization with chicken collagen type II (CII). CCK-8 at different doses was intraperitoneally administered daily for 1 week. Mice treated with CCK-8 at doses of 5 and 10 nmol but not 1 nmol displayed much delayed onset of CIA and significantly lower incidence and decreased severity of arthritis. CCK-8 treatment significantly reduced the production of cytokines (IL-17, IL-23, IL-6 and TNF-α) and chemokines monocyte chemoattractant protein 1 in the joints of arthritic mice or in synovial cell culture supernatant, and increased the levels of IFN-γ and TGF-β. T cells from CCK-8 treated mice proliferated much less, produced low level of IL-17 and high levels of IFN-γ and TGF-β. Moreover, CCK-8 treated mice showed lower levels of CII-specific IgG, particularly that of IgG2a, in sera than those from control mice. These results indicate that CCK-8 is effective in suppressing both inflammatory and Th17 responses in CIA. CCK-8 may represent a new therapeutic modality for rheumatoid arthritis.
Similar content being viewed by others
References
VanderBorght A, Geusens P, Raus J, Stinissen P (2001) The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and immunotherapies. Semin Arthritis Rheum 31:160–175. doi:10.1053/sarh.2001.27736
Zhao JX, Li R, Shi JX, Long L, Li ZG (2008) Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells. Rheumatol Int 29:9–16. doi:10.1007/s00296-008-0634-4
Elena GR, Alejo C, Francisco O, Mario D (2007) Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells. Am J Pathol 170:263–271. doi:10.2353/ajpath.2007.060596
Mario D, Catalina A, Carmen M, Javier L, Rosa PG (2001) Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat Med 7:563–568. doi:10.1038/87887
Janette FC, María Inés VR, Antonio RC (2007) Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 6:169–175. doi:10.1016/j.autrev.2006.10.002
Harrington LE, Mangan PR, Weaver CT (2006) Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 18:349–356. doi:10.1016/j.coi.2006.03.017
Langrish CL, Chen Y, Blumenschein WM et al (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233–240. doi:10.1084/jem.20041257
Lubberts E, Koenders MI, van der Berg W (2005) The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 7:29–37. doi:10.1186/ar1478
Brand DD, Kang AH, Rosloniec EF (2003) Immunopathogenesis of collagen arthritis. Springer Semin Immunopathol 25:3–18. doi:10.1007/s00281-003-0127-1
Elena GR, Alejo C, Nieves V, O’V Francisco, Mario D (2007) Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells. Arthritis Rheum 56:531–543. doi:10.1002/art.22394
Ni ZY, Cong B, Li SJ, Ma CL, Yan YX, Xu JR, Zhang GZ (2007) Effects of cholecystokinin octapeptide on expression of IL-1β, IL-6, IL-4 and IL-10 in lipopolysaccharide-attacked mice. Chin J Pathophysiol 23:331–335
Song N, Li SJ, Cong B et al (2009) Cholecystokinin octapeptide modulates Th1/Th2 imbalance in splenocytes of KLH-immunized mice. Chin J Pathophysiol 25:313–317
Jin YH, Zhao ZS, Cong B, Xu JR, Yao YX, Li SJ, Ling YL (2005) Effect of cholecystokinin octapeptide-8 on the production of matrix metalloproteinases of rat fibroblast-like synovial cell line RSC-364. Chin J Rheumatol 9:193–196
Manni L, Lundeberg T, Tirassa P, Aloe L (2002) Role of cholecystokinin-8 in nerve growth factor and nerve growth factor mRNA expression in carrageenan-induced joint inflammation in adult rats. Rheumatology 41:787–792
Elena GR, Amelia FM, Alejo C, Mario D (2006) Vasoactive intestinal peptide induces CD4+, CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis. Arthritis Rheum 54:864–876. doi:10.1002/art.21652
Kim KS, Choi YH, Kim KH et al (2004) Protective and anti-arthritic effects of deer antler aqua-acupuncture (DAA), inhibiting dihydroorotate dehydrogenase, on phosphate ions mediated chondrocyte apoptosis and rat collagen-induced arthritis. Int Immunopharmacol 4:963–973. doi:10.1016/j.intimp.2004.04.010
Nishikawa M, Myoui A, Tomita T, Takahi K, Nampei A, Yoshikawa H (2003) Prevention of the onset and progression of collagen induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. Arthritis Rheum 48:2670–2681. doi:10.1002/art.11227
Butler DM, Malfait AM, Mason LJ et al (1997) DBA/1 mice expressing the human TNFα transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition. J Immunol 159:2867–2876
Hirayasu K, Kazuko S, Wang YN et al (2006) Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice. Immunology 118:233–239. doi:10.1111/j.1365-2567.2006.02361.x
Seetharaman R, Mora AL, Nabozny G, Boothby M, Chen J (1999) Essential role of T-cell NF-kappa B activation in collagen-induced arthritis. J Immunol 163:1577–1583
Fionula MB, Iain BM (2008) Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 118:3537–3545. doi:10.1172/JCI36389
Anthony DD, Haqqi TM (1999) Collagen-induced arthritis in mice: an animal model to study the pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 17:240–244
O’Garra A (1998) Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275–283. doi:10.1016/S1074-7613(00)80533-6
Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM (2006) Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24:677–688. doi:10.1016/j.immuni.2006.06.002
Corte’s M, Canellada A, Miranda S, Dokmetjian J, Gentile T (2008) Placental secreted factors: their role in the regulation of anti-CII antibodies and amelioration of collagen induced arthritis in rats. Immunol Lett 119:42–48. doi:10.1016/j.imlet.2008.04.001
Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397–440. doi:10.1146/annurev.immunol.14.1.397
Koch AE (2005) Chemokines and their receptors in rheumatoid arthritis: future targets? Arthritis Rheum 52:710–721. doi:10.1002/art.20932
Kuruvilla AP, Shah R, Hochwald GM, Liggitt HD, Palladito MA, Thorbecke GJ (1991) Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 88:2918–2921
Cooper SM, Sriram S, Ranges GE (1988) Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma. J Immunol 141:1958–1962
Boissier MC, Chiocchia G, Bessis N, Hajnal J, Garotta G, Nicoletti F, Fournier C (1995) Biphasic effect of interferon-γ in murine collagen-induced arthritis. Eur J Immunol 25:1184–1190. doi:10.1002/eji.1830250508
Williams RO, Williams DG, Feldmann M, Maini RN (1993) Increased limb involvement in murine collagen-induced arthritis following treatment with anti-interferon-gamma. Clin Exp Immunol 92:323–327. doi:10.1111/j.1365-2249.1993.tb03399.x
Nakajima H, Hiyama Y, Takamori H, Tsukada W (1993) Cell-mediated transfer of collagen-induced arthritis in mice and its application to the analysis of the inhibitory effects of interferon-gamma and cyclophosphamide. Clin Exp Immunol 92:328–335. doi:10.1111/j.1365-2249.1993.tb03400.x
Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Maththys P (1997) Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol 158:5507–5513
Manoury-Schwartz B, Chiocchia G, Bessis N et al (1997) High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol 158:5501–5506
Li S, Ni Z, Cong B, Gao W, Xu S, Wang C, Yao Y, Ma C, Ling Y (2007) CCK-8 inhibits LPS-induced IL-1 beta production in pulmonary interstitial macrophages by modulating PKA, p38, and NF-kappaB pathway. Shock 27:678–686. doi:10.1097/shk.0b013e3180ze26dd
Sheibanie AF, Khayrullina T, Safadi FF, Ganea D (2007) Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis. Arthritis Rheum 56:2608–2619. doi:10.1002/art.22794
Dong C (2006) Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol 6:329–333. doi:10.1038/nri1807
Tato CM, O’Shea JJ (2006) Immunology: what does it mean to be just 17? Nature 441:166–168. doi:10.1038/441166a
Han DY, Cong B, Li SJ et al (2008) Effect of CCK-8 on IL-12 secreted in murine bone marrow-derived dendritic cell induced by LPS. Chin Pharmacol Bull 24:357–361
Wraith DC, Nicolson KS, Whitlet NT (2004) Regulatory CD4+ T cells and the control of autoimmune disease. Curr Opin Immunol 16:695–701. doi:10.1016/j.coi.2004.09.015
Morgan ME, Flierman R, van Duivenvoorde LM et al (2005) Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 52:2212–2221. doi:10.1002/art21195
Mukherjee P, Wu B, Mayton L, Kim SH, Robbins PD, Wooley PH (2003) TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis. Ann Rheum Dis 62:707–714. doi:10.1136/ard.62.8.707
Susumu N, Aya N, Katsuko S, Yoichiro I (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171:6173–6177
Acknowledgments
This work was supported by grants from National Natural Science Foundation of China (No. 30770839); Natural Science Foundation of Hebei Province (No. C2007000833); China Postdoctoral Science Foundation funded project (No. 20080440822).
Conflict of interest statement
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, Q., Cong, B., Shan, B. et al. Cholecystokinin octapeptide exerts its therapeutic effects on collagen-induced arthritis by suppressing both inflammatory and Th17 responses. Rheumatol Int 31, 1291–1298 (2011). https://doi.org/10.1007/s00296-010-1476-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-010-1476-4